Larvol Delta - Biomind-Labs-Announces-the-Start-of-the-FirstEver-Clinical-Trial-Targeting-Depression-and-Anxiety-in-Alzheimers-Disease-With-a-Proprietary-formulation-Based-On-5MeODMT

5-methoxy-N,N-dimethyltryptamine (BMND08) - Biomind

https://www.businesswire.com/news/home/20230425005788/en/Biomind-Labs-Announces-the-Start-of-the-First-Ever-Clinical-Trial-Targeting-Depression-and-Anxiety-in-Alzheimer%E2%80%99s-Disease-With-a-Proprietary-formulation-Based-On-5-MeO-DMT

Apr 25, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next